browse Browse

pac.dog pac.dog / Lobbying

1st Quarter - Report · 2026

Filing UUID
8b0c29d9-e6af-4e47-8953-6c568a1ec49e
Type
Q1 — 1st Quarter - Report
Period
first_quarter
Year
2026
Posted
2026-04-20 20:44:55
Income (reported)
Expenses (reported)
$3,490,000
Expenses method
A
Filing document
Open on lda.senate.gov
Registrant (lobbying firm)

THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)

Health Services

Contact
KIMBERLEY SNOW
Phone
+1 202-719-6760
Address
zip:20004, city:WASHINGTON, state:DC, street:701 PENNSYLVANIA AVENUE, NW SUITE 720
Client

THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)

State
DC
Country
US
Government-entity client
false
Effective date
2012-10-17
Issues lobbied + lobbyists (5)

MMM — Medicare/Medicaid

Issues related to prior authorization; ACCESS (Advancing Chronic Care with Effective, Scalable Solutions) model

Lobbyists:
  • COURTNEY LAWRENCE
  • KARA SMITH
  • JESSICA HATCHER — covered position: Rep. Jake Auchincloss (D-MA) - Legislative Director 1/2021-3/2023, Rep. Pramila Jayapal (D-WA) - Senior Legislative Assistant, 5/2020-12/2020; Legislative Assistant, 4/2018-4/2020 [new]
  • mr CHRISTOPHER HARTMANN
  • ms KRISTINA KAYE WEGER
  • JULIEN MITCHELL RELFE

Government entities lobbied: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

HCR — Health Issues

Issues relating to implementation of the No Surprises Act

Lobbyists:

Government entities lobbied: Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Labor, Dept of (DOL); SENATE

DEF — Defense

H.R. 3838/S2296 Pharmacy issues related to the National Defense Authorization Act, FY2026 HR. 6400 / S. 4106 - Rx Access, Choice, Cost Equity, and Supply Stability (Rx ACCESS) Act

Lobbyists:
  • mr CHRISTOPHER HARTMANN
  • JULIEN MITCHELL RELFE
  • KARA SMITH
  • JESSICA HATCHER — covered position: Rep. Jake Auchincloss (D-MA) - Legislative Director 1/2021-3/2023, Rep. Pramila Jayapal (D-WA) - Senior Legislative Assistant, 5/2020-12/2020; Legislative Assistant, 4/2018-4/2020 [new]
  • ms KRISTINA KAYE WEGER
  • COURTNEY LAWRENCE

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

PHA — Pharmacy

S. 1542/H.R.2214, the DRUG Act; H.R. 5378 Lower Costs, More Transparency Act; S. 1339, Pharmacy Benefit Manager Reform Act; S.526, Pharmacy Benefit Manager Transparency Act; P.L. 119-75 Consolidated Appropriations Act, 2026 (H.R.7148) Issues related to the specialty drug market. H.R. 5582/S. 2355, Patients Deserve Price Tags Act

Lobbyists:
  • mr CHRISTOPHER HARTMANN
  • JULIEN MITCHELL RELFE
  • KARA SMITH
  • ms KRISTINA KAYE WEGER
  • JESSICA HATCHER — covered position: Rep. Jake Auchincloss (D-MA) - Legislative Director 1/2021-3/2023, Rep. Pramila Jayapal (D-WA) - Senior Legislative Assistant, 5/2020-12/2020; Legislative Assistant, 4/2018-4/2020 [new]
  • COURTNEY LAWRENCE

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

LBR — Labor Issues/Antitrust/Workplace

Issues related to competition in the health care marketplace.

Lobbyists:
  • JULIEN MITCHELL RELFE
  • ms KRISTINA KAYE WEGER
  • KARA SMITH
  • mr CHRISTOPHER HARTMANN
  • JESSICA HATCHER — covered position: Rep. Jake Auchincloss (D-MA) - Legislative Director 1/2021-3/2023, Rep. Pramila Jayapal (D-WA) - Senior Legislative Assistant, 5/2020-12/2020; Legislative Assistant, 4/2018-4/2020 [new]
  • COURTNEY LAWRENCE

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.